TILT Holdings (TLLTF) Non-Current Deferred Tax Liability (2021 - 2025)
TILT Holdings (TLLTF) reported Non-Current Deferred Tax Liability of $697000.0 for Q2 2025, up 47.67% on a YoY basis from $472000.0 in Q2 2024, and little changed quarter-over-quarter from $697000.0 in Q1 2025.
TILT Holdings (TLLTF) Non-Current Deferred Tax Liability (2021 - 2025) Analysis & Trends
TILT Holdings has reported Non-Current Deferred Tax Liability for 5 years, with the latest figure at $697000.0 in Q2 2025.
- For the quarter ending Q2 2025, Non-Current Deferred Tax Liability rose 47.67% year-over-year to $697000.0; the trailing twelve-month figure through Jun 2025 stood at $697000.0 (up 47.67% YoY), and the FY2024 full-year result was $697000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q2 2025 stood at $697000.0, roughly flat from $697000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $2.2 million in Q1 2023, with the low at $85000.0 in Q4 2021.
- Historically, Non-Current Deferred Tax Liability has averaged $882571.4 across 5 years, with a median of $697000.0 in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability surged 1515.29% — and 2025, when it jumped 47.67%.
- TILT Holdings' Non-Current Deferred Tax Liability stood at $85000.0 in 2021, then surged by 1515.29% to $1.4 million in 2022, then surged by 57.1% to $2.2 million in 2023, then sank by 67.69% to $697000.0 in 2024, then changed by 0.0% to $697000.0 in 2025.
- The last three Non-Current Deferred Tax Liability figures came in at $697000.0 (Q2 2025), $697000.0 (Q1 2025), and $697000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 697,000.00 |
| Jun 30, 2025 | 697,000.00 |
| Mar 31, 2025 | 697,000.00 |
| Mar 31, 2025 | 697,000.00 |
| Dec 31, 2024 | 697,000.00 |
| Dec 31, 2024 | 697,000.00 |
| Jun 30, 2024 | 472,000.00 |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2023 | 2.16 Mn |
| Mar 31, 2023 | 2.16 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | 85,000.00 |
| Dec 31, 2021 | 85,000.00 |